Close
Back to NBSE Stock Lookup

(NBSE) – FDA

Oct 21, 2022 08:01 AM NeuBase Therapeutics (NBSE) Announces Gene Editing Research Agreement with Global Healthcare Company
Jun 8, 2021 12:30 PM NeuBase Therapeutics (NBSE) Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth
Dec 16, 2020 06:40 AM

Back to NBSE Stock Lookup